Maeda, ShinShinMaedaLI-CHUNG HSULiu, HongjunHongjunLiuBankston, Laurie ALaurie ABankstonIimura, MitsutoshiMitsutoshiIimuraKagnoff, Martin FMartin FKagnoffEckmann, LarsLarsEckmannKarin, MichaelMichaelKarin2024-04-262024-04-262005-02-0400368075https://scholars.lib.ntu.edu.tw/handle/123456789/642068Variants of NOD2, an intracellular sensor of bacteria-derived muramyl dipeptide (MDP), increase susceptibility to Crohn's disease (CD). These variants are thought to be defective in activation of nuclear factor kappaB (NF-kappaB) and antibacterial defenses, but CD clinical specimens display elevated NF-kappaB activity. To illuminate the pathophysiological function of NOD2, we introduced such a variant to the mouse Nod2 locus. Mutant mice exhibited elevated NF-kappaB activation in response to MDP and more efficient processing and secretion of the cytokine interleukin-1beta (IL-1beta). These effects are linked to increased susceptibility to bacterial-induced intestinal inflammation and identify NOD2 as a positive regulator of NF-kappaB activation and IL-1beta secretion.en[SDGs]SDG3Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processingjournal article10.1126/science.1103685156920522-s2.0-13244277880https://scholars.lib.ntu.edu.tw/handle/123456789/313651http://www.scopus.com/inward/record.url?eid=2-s2.0-13244277880&partnerID=MN8TOARS